Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland

NCT05232786 | Completed

• 2 other identifiers: DAS-005U1111-1266-4398
• Study Type: observational
• Target: 1,152
• Locations: 1 country
• Sites: 1

Brief Summary

ACTION Switzerland is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Conditions

Obesity

Outcome Measures

Primary Outcomes (5)

• Weight loss motivators

  Multi-select from defined list

  At the time of survey response (Day 1)

• Proportion of PLwO who made serious weight loss effort

  Number of weight loss efforts; percentage of patients

  At the time of survey response (Day 1)

• Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs

  5-point Likert scales (e.g., agreement, impact, frequency) \- Proportion of responses in each category will be reported.

  At the time of survey response (Day 1)

• Weight loss barriers

  Multi-select from defined list

  At the time of survey response (Day 1)

• Weight loss management

  Multi-select from defined list

  At the time of survey response (Day 1)

Study Arms (2)

People / Person Living with Obesity (PLwO)

From online, general population consumer panels

Other: No treatment given

Health Care Professionals (HCPs)

HCPs treating people who have obesity

Other: No treatment given

Interventions

No treatment given OTHER

No treatment given

Health Care Professionals (HCPs); People / Person Living with Obesity (PLwO)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management

You may qualify if:

• People Living with Obesity:
• Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
• Male, female or other, aged above or equal to 18 years at the time of signing informed consent
• Lives in Switzerland (minimum quota based on primary language: German, French and Italian to ensure adequate samples for sub-group analysis)
• Current BMI of 30 Kg/m\^2 or greater calculated based on self-reported height and weight
• Health Care Professionals:
• Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
• Male, female or other, aged above or equal to 18 years at the time of signing informed consent.
• Physician
• Dietitian who is a member of the SVDE ASDD (Swiss Association of Dietitians) and services covered by the compulsory health insurance
• Primary Care Providers (PCPs) whose specialty is Family Practice, General Practice, General Internal Medicine (who is focused on primary care)
• Non-PCP Specialties whose specialty is Obstetrics/Gynaecologists, Endocrinologists/Diabetologists. Psychiatrists, General Internal Medicine with focus on diabetes and/or obesity and bariatric surgeons who are involved in the management of obesity in addition to surgery
• Practices in Switzerland
• In clinical practice for greater than or equal to 2 years
• Spends at least 50% time in direct patient care

You may not qualify if:

• People Living with Obesity:
• Previous participation in this study. Participation is defined as having given online consent in this study
• Currently pregnant
• Participates in intense fitness or body building programs
• Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
• Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
• Health Care Providers:
• Previous participation in this study. Participation is defined as having given informed consent in this study.
• Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Sponsors & Collaborators

• Novo Nordisk A/S: lead

Study Sites (1)

Novo Nordisk Investigational Site

Zurich, Switzerland

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Clinical Transparency (dept. 2834)

  Novo Nordisk A/S

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 12, 2022
• First Posted: February 10, 2022
• Study Start: March 8, 2022
• Primary Completion: April 8, 2022
• Study Completion: April 8, 2022
• Last Updated: October 26, 2022

Record last verified: 2022-10

Data Sharing

• IPD Sharing: Will share

Locations

CH (1)